South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling
Project Number5P30GM140964-04
Contact PI/Project LeaderTEW, KENNETH D.
Awardee OrganizationMEDICAL UNIVERSITY OF SOUTH CAROLINA
Description
Abstract Text
Overall – Abstract
With Phase III COBRE support, the South Carolina Center in Oxidants, Redox Balance, and Stress Signaling
(Redox COBRE) at the Medical University of South Carolina (MUSC) will complete its transition to long-term
sustainability as a nationally competitive multidisciplinary research program in redox pathobiology. During
Phases I and II, our Redox COBRE was successful in its efforts to (i) expand the critical mass of funded
investigators at MUSC studying the causal role of redox pathways and metabolic dysfunction in a wide range of
human pathologies (cancer, cardiovascular and neurodegenerative diseases, diabetes, gastrointestinal
disorders and drug addiction) and (ii) develop advanced scientific core resources offering a broad range of
capabilities for investigating the biologically significant effects of oxidative stress. Our current core membership
comprises 44 senior and junior faculty members that have received more than $51 million in awards since the
program’s inception. To date, the Redox COBRE has mentored a total of 20 target faculty (junior investigators +
pilot project-supported PIs). Of these individuals, 10 have been promoted and 16 have been retained at our
institution. As a group, these faculty members have published more than 250 peer-reviewed papers and secured
56 extramural grant awards (including 31 NIH grants (PI role) of which 16 are R01 awards and 8 are SBIR/STTR-
supported start-ups). The major components of this Phase III proposal are: (1) an Administrative Core providing
organizational, coordinating, fiscal and accountability functions; (2) an Analytical Redox Core delivering
analytical biochemistry services for quantification of redox-sensitive molecule abundance and redox-based
changes in cellular homeostasis; (3) a Proteomics Core that offers state-of-the-art mass spectrometry (MS) and
MS-imaging capabilities; (4) a Cell & Molecular Redox Imaging Core that provides cell and tissue-based
confocal, multiphoton and super-resolution microscopic imaging; and (5) a Pilot Projects Program (PPP) that
fosters research endeavors utilizing Center resources and facilitates collaborations with Redox COBRE
members. Towards our objective of becoming a stand-alone Center of Redox Biology and Signaling (abbreviated
to “Redox Center”), we will build upon our substantial scientific and institutional achievements, to: (Aim 1)
enhance the function and efficiencies of our scientific cores, achieving optimal positioning to serve Center
thematic and translational goals and achieve/ maintain sustainability; (Aim 2) leverage the PPP to grow center
membership and promote the importance of translational redox signaling research in the context of human
disease; (Aim 3) develop the research portfolio and connections between the Redox COBRE and other IDeA
programs to establish ourselves as a national presence coalescing various disciplines and areas of expertise.
Thus, we are seeking to establish a strategic position for long-term success as an emergent, University-
designated Redox Center that will be one of few national resources for investigators to utilize or develop new
technologies, therapeutics and interventions targeting pathological redox pathways.
Public Health Relevance Statement
Overall – Narrative
While oxygen provides the most efficient way to produce energy through oxidative phosphorylation, paradoxically
it also produces toxic byproducts. Through adaptation, organisms have evolved numerous redox based stress
pathways to counteract this toxicity. In human diseases, these pathways can sometimes malfunction leading to
a broad range of human maladies. This COBRE seeks to support faculty and their research in these areas with
an agnostic viewpoint on the choice of disease. Our overall goal continues to be to build a sustainable Center
that can provide a focal effort to comprehend the integral importance of redox stress signaling in human diseases
and the treatment thereof.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AbbreviationsAccountabilityAchievementAdvisory CommitteesAnalytical BiochemistryAreaAutomobile DrivingAwardBioenergeticsBiologyBiomedical ResearchBiotechnologyCancer CenterCardiovascular DiseasesCellsCenters of Research ExcellenceCollaborationsComplementCore FacilityDiabetes MellitusDisciplineDiseaseDrug AddictionEconomicsEngineeringEquilibriumEquipmentExtramural ActivitiesFacultyFinancial SupportFosteringFundingGastrointestinal AgentsGastrointestinal DiseasesGoalsGrantGrowthHealthHomeostasisHumanHuman PathologyImageIndividualInfrastructureInstitutionInterdisciplinary StudyInterventionMalignant NeoplasmsMass Spectrum AnalysisMedicalMedicineMentorsMetabolic dysfunctionMissionModelingMolecularMusculoskeletalNational Institute of General Medical SciencesNeurodegenerative DisordersOrganismOxidantsOxidation-ReductionOxidative PhosphorylationOxidative StressOxygenPaperPathologicPathway interactionsPeer ReviewPhasePilot ProjectsPositioning AttributeProteomicsPublished CommentPublishingRecoveryResearchResearch InfrastructureResearch PersonnelResource SharingResourcesRoleScientific Advances and AccomplishmentsSecureServicesSignal TransductionSmall Business Innovation Research GrantSmall Business Technology Transfer ResearchSourceSouth CarolinaStressTalentsTeacher Professional DevelopmentTherapeuticTissuesToxic effectTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkforce Developmentbasecareercollaborative environmentcollegecommercial applicationcostdesignexperiencefaculty supporthuman diseaseimaging capabilitiesimprovedinfrastructure developmentmass spectrometric imagingmembermicroscopic imagingmulti-photonmultidisciplinarynew technologynoveloutreachprogramsrecruitsuccesstargeted treatmenttranslational goalultra high resolution
No Sub Projects information available for 5P30GM140964-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30GM140964-04
Patents
No Patents information available for 5P30GM140964-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30GM140964-04
Clinical Studies
No Clinical Studies information available for 5P30GM140964-04
News and More
Related News Releases
No news release information available for 5P30GM140964-04
History
No Historical information available for 5P30GM140964-04
Similar Projects
No Similar Projects information available for 5P30GM140964-04